Attention Denver Residents: you may be entitled to compensation – call today if you have used Ozempic and subsequently developed gastroparesis, cyclic vomiting syndrome, and/or gallbladder disease.
Ozempic, aka semaglutide, is an injectable medication that was originally approved for the treatment of Type 2 diabetes. It has since become a wildly popular form of medical weight loss. Between October and November of 2022 (just three months), doctors issued over 9 million prescriptions for Ozempic, Weygovy, Mounjaro, and similar weight loss drugs.
Unfortunately, many patients have begun to develop unpleasant and even debilitating side effects. These include gastroparesis, cyclic vomiting syndrome, and gallbladder disease, all of which are the source of the current lawsuit against Ozempic in Denver and elsewhere. The lawsuit alleges that Ozempic failed to adequately warn patients of the potential risks associated with taking the drug. The lawsuit is not limited to Ozempic: it also includes the manufacturers Weygovy, Mounjaro, Trulicity, and Rybelsus.
Gastroparesis occurs when the muscles in the stomach are unable to properly move food into the small intestine. Also called “delayed gastric emptying,” it is a serious and usually rare condition that causes vomiting, nausea, abdominal pain, bloating, and other unpleasant side effects. Ironically, it is more common among type 2 diabetes patients whose blood sugar is poorly controlled. There is no cure, unfortunately, though symptoms can be managed with dietary changes and medication.
Cyclic vomiting syndrome is another potential gastrointestinal side effect of Ozempic and other injectable weight loss products. Cyclic vomiting involves bouts of repeated and severe vomiting. These episodes can last days and potentially lead to malnutrition and dehydration, among other complications.
The Denver Ozempic lawsuit aims to hold companies manufacturing these products accountable for not warning of the risk of gastroparesis and other digestive issues.
The reason why Ozempic increases the risk for gastroparesis is not fully understood. However, it may involve the same mechanism that makes it so effective for weight loss. Ozempic and other medical weight loss drugs are in a class called GLP-1 receptor agonists. It effectively mimics the hormone that is released into the bloodstream after eating. This signals the body to feel full sooner than usual.
GLP-1 also causes delayed emptying of the stomach, which maintains a feeling of fullness and reduces appetite. Higher doses may signal the muscles in the stomach to stop working all together, resulting in gastroparesis.
There is also growing evidence that the use of Ozempic and other weight loss drugs increases the risk of gallstones and gallbladder disease. Gallstones can be excruciating, and surgery is often required for frequent attacks.
Gallbladder removal (called a “cholecystectomy”) can have complications. Post-cholecystectomy Syndrome is a lifelong condition that involves nausea, heartburn, pain, fatty food intolerance, jaundice, and more.
Denver’s Ozempic lawsuit highlights the fact that the potential risk of developing gallbladder disease was not included on the label until very recently.
Gallstones are hardened deposits of bile, calcium, and cholesterol. Ozempic causes rapid weight loss, which is associated with an increase in cholesterol and bilirubin. Cholesterol is broken down by the liver into bile, which is secreted by the gallbladder. An increase in cholesterol is therefore linked to an increase in bile, which increases the probability of gallstone formation.
The increased risk of gallstones was only very recently added to the label for Ozempic and similar drugs. Those who developed symptoms prior to the updated label may be entitled to compensation via the Denver Ozempic lawsuit.
Among other things, affected individuals may be able to claim the following in the multidistrict litigation lawsuit against Novo Disk, the manufacturer of brand name semaglutide (Ozempic):
Lost wages
Medical expenses
Loss of earning capacity
Pain and suffering
The amounts will vary depending on the specifics of your case, but your Ozempic lawsuit attorney will work to ensure the best possible outcome.
If you live in Denver or the surrounding area, have used Ozempic, and your doctor diagnosed you with severe gastroparesis and/or cyclic vomiting syndrome, you may have grounds for a legal case. Likewise, if you developed gallbladder issues while taking Ozempic, Mounjaro, Weygovy, Trulicity, or Rybelsus, you may be entitled to compensation.
Drug makers have a moral and legal obligation to fully disclose the risks associated with their products. Patients and doctors deserve to make informed decisions about their health care, weighing the benefits of a medication against its potential risks.
Boesen Law is taking your calls today to evaluate your case and share more information regarding the Ozempic lawsuit in Denver.
If you suspect the use of Ozempic has caused health problems contact Boesen Law, a top Denver area attorney who specializes in mass tort MDL cases against big pharma. Your first consultation is always free. Go online or call 303-999-9999 today.
5675 DTC Blvd., Suite 250, Greenwood Village, CO 80111
Phone: 303-999-9999
"Spoke with john and he was extremely knowledgeable and really was of great help. I strongly advise anyone to reach out to Boesen law. They were wonderful."
"Boesen Law met and exceeded my expectations. They were attentive and responsive, and they got me the results I was expecting. I recommend Boesen Law for your bodily injury claims!"
"The day after my accident, I was so badly hurt, and knew I needed a good lawyer ASAP. I went to Avvo, and reached out to maybe three options, one..."
